Item Type | Name |
Academic Article
|
Enhanced staging and all chemotherapy preoperatively in patients with potentially resectable gastric carcinoma.
|
Academic Article
|
CPT-11 plus cisplatin in patients with advanced, untreated gastric or gastroesophageal junction carcinoma: results of a phase II study.
|
Academic Article
|
Irinotecan/cisplatin in advanced, treated gastric or gastroesophageal junction carcinoma.
|
Academic Article
|
Adjuvant and neoadjuvant therapy for gastric cancer.
|
Academic Article
|
Does neoadjuvant treatment for gastric cancer patients with positive peritoneal cytology at staging laparoscopy improve survival?
|
Academic Article
|
Intensity-modulated radiation therapy with concurrent chemotherapy as preoperative treatment for localized gastric adenocarcinoma.
|
Concept
|
Stomach Neoplasms
|
Concept
|
Stomach
|
Academic Article
|
Laparoscopy in 533 patients with abdominal malignancy.
|
Academic Article
|
Association of gastric adenocarcinoma with the HLA class II gene DQB10301.
|
Academic Article
|
Adjuvant therapy for resectable gastric adenocarcinoma: preoperative and postoperative chemotherapy trials.
|
Academic Article
|
Response to neoadjuvant chemotherapy best predicts survival after curative resection of gastric cancer.
|
Academic Article
|
Induction of neuropilin-1 and vascular endothelial growth factor by epidermal growth factor in human gastric cancer cells.
|
Academic Article
|
Paclitaxel-based chemoradiotherapy in localized gastric carcinoma: degree of pathologic response and not clinical parameters dictated patient outcome.
|
Academic Article
|
Clinical stage after preoperative chemoradiation is a better predictor of patient outcome than the baseline stage for localized gastric cancer.
|
Academic Article
|
Non-random primary and secondary chromosomal abnormalities in human gastric cancers.
|
Academic Article
|
A pilot study of preoperative chemoradiotherapy for resectable gastric cancer.
|
Academic Article
|
Effects of combination anti-vascular endothelial growth factor receptor and anti-epidermal growth factor receptor therapies on the growth of gastric cancer in a nude mouse model.
|
Academic Article
|
ZD6126 inhibits orthotopic growth and peritoneal carcinomatosis in a mouse model of human gastric cancer.
|
Academic Article
|
Clinicopathologic behavior of gastric adenocarcinoma in Hispanic patients: analysis of a single institution's experience over 15 years.
|
Academic Article
|
Surgical pathology stage by American Joint Commission on Cancer criteria predicts patient survival after preoperative chemoradiation for localized gastric carcinoma.
|
Academic Article
|
Impact of induction chemotherapy and preoperative chemoradiotherapy on operative morbidity and mortality in patients with locoregional adenocarcinoma of the stomach or gastroesophageal junction.
|
Academic Article
|
Incidence, natural history, and patterns of locoregional recurrence in gastric cancer patients treated with preoperative chemoradiotherapy.
|
Academic Article
|
Potentially resectable gastric carcinoma: current approaches to staging and preoperative therapy.
|
Academic Article
|
Phase II study of Taxol in patients with advanced gastric carcinoma.
|
Academic Article
|
Oral etoposide for patients with metastatic gastric adenocarcinoma.
|
Academic Article
|
Irinotecan plus cisplatin in advanced gastric or gastroesophageal junction carcinoma.
|
Academic Article
|
Association between expression of transcription factor Sp1 and increased vascular endothelial growth factor expression, advanced stage, and poor survival in patients with resected gastric cancer.
|
Academic Article
|
Multi-institutional trial of preoperative chemoradiotherapy in patients with potentially resectable gastric carcinoma.
|
Academic Article
|
Prognostic significance of CpG island methylator phenotype and microsatellite instability in gastric carcinoma.
|
Academic Article
|
Hepatic resection: the last surgical frontier for colorectal cancer.
|
Academic Article
|
Outcome of gastric cancer patients after successful gastrectomy: influence of the type of recurrence and histology on survival.
|
Academic Article
|
Factors influencing the volume-outcome relationship in gastrectomies: a population-based study.
|
Academic Article
|
Clinical benefit of palliative radiation therapy in advanced gastric cancer.
|
Academic Article
|
The impact of ethnicity on the presentation and prognosis of patients with gastric adenocarcinoma. Results from the National Cancer Data Base.
|
Academic Article
|
Multimodality approaches to localized gastric cancer.
|
Academic Article
|
Surgical approaches to gastric cancer.
|
Academic Article
|
A RAND/UCLA appropriateness study of the management of familial gastric cancer.
|
Academic Article
|
Defining surgical quality in gastric cancer: a RAND/UCLA appropriateness study.
|
Academic Article
|
Subaquatic laparoscopy for staging of intraabdominal malignancy.
|
Academic Article
|
ZD6474, a vascular endothelial growth factor receptor tyrosine kinase inhibitor with additional activity against epidermal growth factor receptor tyrosine kinase, inhibits orthotopic growth and angiogenesis of gastric cancer.
|
Academic Article
|
What provider volumes and characteristics are appropriate for gastric cancer resection? Results of?an?international RAND/UCLA expert?panel.
|
Academic Article
|
Gastric carcinoma.
|
Academic Article
|
Lymphadenectomy for gastric cancer.
|
Academic Article
|
What studies are appropriate and necessary for staging gastric adenocarcinoma? Results of an international RAND/UCLA expert panel.
|
Academic Article
|
Processes of care in the multidisciplinary treatment of gastric cancer: results of a RAND/UCLA expert panel.
|
Academic Article
|
Long-term survival in patients with metastatic gastric and gastroesophageal cancer treated with surgery.
|
Academic Article
|
Predictors of Survival in Patients with Resectable Gastric Cancer Treated with Preoperative Chemoradiation Therapy and Gastrectomy.
|
Academic Article
|
Postoperative Morbidity and Mortality Rates are Not Increased for Patients with Gastric and Gastroesophageal Cancer Who Undergo Preoperative Chemoradiation Therapy.
|
Academic Article
|
Defining the Impact of Surgical Approach on Perioperative Outcomes for Patients with Gastric Cardia Malignancy.
|
Academic Article
|
Comprehensive geriatric assessment in patients with gastric and gastroesophageal adenocarcinoma undergoing gastrectomy.
|
Academic Article
|
Long-Term Survival in Patients with Gastroesophageal Junction Cancer Treated with Preoperative Therapy: Do Thoracic and Abdominal Approaches Differ?
|
Academic Article
|
Prognosis of gastric adenocarcinoma patients with various burdens of peritoneal metastases.
|
Academic Article
|
Frequency of Resection After Preoperative Chemotherapy or Chemoradiotherapy for Gastric Adenocarcinoma.
|
Academic Article
|
Yield of Staging Laparoscopy and Lavage Cytology for Radiologically Occult Peritoneal Carcinomatosis of Gastric Cancer.
|
Academic Article
|
Survival rates in T1 and T2 gastric cancer: A Western report.
|
Academic Article
|
Race Is a Risk for Lymph Node Metastasis in Patients With Gastric Cancer.
|
Academic Article
|
Co-morbidities Rather than Age Impact Outcomes in Patients Receiving Preoperative Therapy for Gastroesophageal Adenocarcinoma.
|
Academic Article
|
Multimodality Treatment of Gastric Lymphoma.
|
Academic Article
|
Patterns of Initial Recurrence in Gastric Adenocarcinoma in the Era of Preoperative Therapy.
|
Academic Article
|
Lessons learned from a phase II clinical trial of laparoscopic HIPEC for gastric cancer.
|
Academic Article
|
Evaluation of the American Joint Committee on Cancer 8th edition staging system for gastric cancer patients after preoperative therapy.
|
Academic Article
|
Phase II Trial of Laparoscopic Hyperthermic Intraperitoneal Chemoperfusion for Peritoneal Carcinomatosis or Positive Peritoneal Cytology in Patients with Gastric Adenocarcinoma.
|
Academic Article
|
Left Gastric Artery Lymph Nodes Should Be Included in D1 Lymph Node Dissection in Gastric Cancer.
|
Academic Article
|
Racial disparities in preoperative chemotherapy use in gastric cancer patients in the United States: Analysis of the National Cancer Data Base, 2006-2014.
|
Academic Article
|
Central Lymph Node Metastasis in Gastric Cancer Is Predictive of Survival After Preoperative Therapy.
|
Academic Article
|
Nodal Downstaging in Gastric Cancer Patients: Promising Survival if ypN0 is Achieved.
|
Academic Article
|
Preoperative chemoradiation therapy induces primary-tumor complete response more frequently than chemotherapy alone in gastric cancer: analyses of the National Cancer Database 2006-2014 using propensity score matching.
|
Academic Article
|
Preoperative Chemoradiation Therapy Does Not Increase Risk of Anastomotic Leak in Patients With Gastric Cancer.
|
Academic Article
|
Preoperative Therapy for Gastric Adenocarcinoma is Protective for Poor Oncologic Outcomes in Patients with Complications After Gastrectomy.
|
Academic Article
|
Surgeon Assessment of Gastric Cancer Lymph Node Specimens with a Video of Technique.
|
Academic Article
|
Repeat staging laparoscopy for gastric cancer after preoperative therapy.
|
Academic Article
|
The ypT category does not impact overall survival in node negative gastric cancer.
|
Academic Article
|
Laparoscopic Hyperthermic Intraperitoneal Chemotherapy is Safe for Patients with Peritoneal Metastases from Gastric Cancer and May Lead to Gastrectomy.
|
Academic Article
|
Trends in Volume-Outcome Relationship in Gastrectomies in Texas.
|
Academic Article
|
Characteristics and Survival of Gastric Cancer Patients with Pathologic Complete Response to Preoperative Therapy.
|
Academic Article
|
Prognostic Value of Lymph Node Yield After Neoadjuvant Chemoradiation for Gastric Cancer.
|
Academic Article
|
Yield of peritoneal cytology in staging patients with gastric and gastroesophageal cancer.
|
Academic Article
|
Linitis Plastica: a Distinct Type of Gastric Cancer.
|
Academic Article
|
Phase I Trial of Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) with Cisplatin, Mitomycin, and Paclitaxel in Patients with Gastric Adenocarcinoma and Associated Carcinomatosis or Positive Cytology.
|
Academic Article
|
Staging laparoscopy and peritoneal cytology in patients with early stage gastric adenocarcinoma.
|
Academic Article
|
Preoperative Chemoradiation Versus Chemotherapy in Gastroesophageal Junction Adenocarcinoma.
|
Academic Article
|
Fluorescent-Image Guidance in Robotic Subtotal Gastrectomy.
|
Academic Article
|
Impact of tumor regression grade on recurrence after preoperative chemoradiation and gastrectomy for gastric cancer.
|
Academic Article
|
Tumor Regression Grade in Gastric Cancer After Preoperative Therapy.
|
Academic Article
|
A Phase II Trial of Cytoreduction, Gastrectomy, and Hyperthermic Intraperitoneal Perfusion with Chemotherapy for Patients with Gastric Cancer and Carcinomatosis or Positive Cytology.
|
Academic Article
|
Factors Associated with Resection and Survival After Laparoscopic HIPEC for Peritoneal Gastric Cancer Metastasis.
|
Academic Article
|
Chemotherapy Versus Chemotherapy Plus Chemoradiation as Preoperative Therapy for Resectable Gastric Adenocarcinoma: A Propensity Score-Matched Analysis of a Large, Single-Institution Experience.
|
Academic Article
|
Laparoscopic HIPEC for Low-Volume Peritoneal Metastasis in Gastric and Gastroesophageal Adenocarcinoma.
|
Academic Article
|
Hereditary diffuse gastric cancer: updated clinical practice guidelines.
|
Academic Article
|
Relationship between initial management strategy and survival in patients with gastric outlet obstruction due to gastric cancer.
|
Academic Article
|
Concurrent lymphovascular and perineural invasion after preoperative therapy for gastric adenocarcinoma is associated with decreased survival.
|
Academic Article
|
Robotic Proximal Gastrectomy with Double-Tract Reconstruction for Gastroesophageal Junction Cancer.
|
Academic Article
|
Robotic D2 Total Gastrectomy with Fluorescent Lymphatic Mapping for Gastric Cancer: Effective Use of the 4th Arm.
|
Academic Article
|
Determinants of Survival for Patients with Neoadjuvant-Treated Node-Negative Gastric Cancer.
|
Academic Article
|
Benchmarks for nodal yield and ratio for node-positive gastric cancer.
|
Academic Article
|
Chemotherapy Versus Chemotherapy Plus Chemoradiation as Neoadjuvant Therapy for Resectable Gastric Adenocarcinoma: A Multi-institutional Analysis.
|
Academic Article
|
Implementation of a perioperative-enhanced recovery protocol in patients undergoing open gastrectomy for gastric cancer.
|
Academic Article
|
Analysis of Opioid Use in Patients Undergoing Open Versus Robotic Gastrectomy.
|
Academic Article
|
Evidence-Based Surgical Approach to Gastroesophageal Junction Cancer: How We Do Robotic Transhiatal Lower Mediastinal Dissection and Esophagojejunostomy.
|
Academic Article
|
ASO Author Reflections: Robotic Transabdominal Approach for Gastroesophageal Junction Cancers in the Era of Multidisciplinary Treatment.
|
Academic Article
|
Short-Term and Textbook Surgical Outcomes During the Implementation of a Robotic Gastrectomy Program.
|
Academic Article
|
Clinical Impact of Positive Surgical Margins in Gastric Adenocarcinoma in the Era of Preoperative Therapy.
|
Academic Article
|
Trans-pacific multicenter collaborative study of minimally invasive proximal versus total gastrectomy for proximal gastric and gastroesophageal junction cancers.
|
Academic Article
|
High symptom burden in patients undergoing gastrectomy for cancer.
|
Academic Article
|
Updated Analysis of a Phase 2 Trial of Cytoreduction, Gastrectomy, and Hyperthermic Intraperitoneal Perfusion with Chemotherapy for Patients with Peritoneal Carcinoma from Gastric Cancer.
|
Academic Article
|
Clinical practice guidelines for esophagogastric junction cancer: Upper GI Oncology Summit 2023.
|